-
公开(公告)号:PL371429A1
公开(公告)日:2005-06-13
申请号:PL37142903
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H J , VAN STUIVENBERG HERMAN H , DIJKSMAN JESSICA A R , MCCREARY ANDREW C
IPC: A61K31/425 , A61K31/426 , A61K31/427 , C07D277/20 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification
-
公开(公告)号:CA2462692A1
公开(公告)日:2003-09-25
申请号:CA2462692
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: VAN STUIVENBERG HERMAN H , HERREMANS ARNOLDUS H J , KRUSE CORNELIS G , LANGE JOSEPHUS H M , DIJKSMAN JESSICA A R , MCCREARY ANDREW C
IPC: C07D277/20 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1- receptor. The compounds have the general formula (I) wherein R and R1-R4 hav e the meanings given in the specification.
-
公开(公告)号:AU2003219164B2
公开(公告)日:2008-07-17
申请号:AU2003219164
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: STUIVENBERG HERMAN H VAN , LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H J , MCCREARY ANDREW C , DIJKSMAN JESSICA A R
IPC: C07D277/20 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification
-
公开(公告)号:BR0306150A
公开(公告)日:2004-10-19
申请号:BR0306150
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H J , STUIVENBERG HERMAN H VAN , DIJKSMAN JESSICA A R , MCCREARY ANDREW C
IPC: C07D277/20 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification
-
公开(公告)号:AU2003219164A1
公开(公告)日:2003-09-29
申请号:AU2003219164
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H J , STUIVENBERG HERMAN H VAN , DIJKSMAN JESSICA A R , MCCREARY ANDREW C
IPC: C07D277/20 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification
-
公开(公告)号:CA2462692C
公开(公告)日:2010-11-09
申请号:CA2462692
申请日:2003-03-17
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H J , VAN STUIVENBERG HERMAN H , DIJKSMAN JESSICA A R , MCCREARY ANDREW C
IPC: C07D277/20 , C07D277/68 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification.
-
公开(公告)号:ZA200404742B
公开(公告)日:2005-08-29
申请号:ZA200404742
申请日:2004-06-15
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , HERREMANS ARNOLDUS H J , DIJKSMAN JESSICA A R , KRUSE CORNELIS G , STUIVENBERG HERMAN H VAN , MCCREARY ANDREW C
IPC: A61K31/425 , A61K31/426 , A61K31/427 , C07D277/20 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12 , C07D , A61K , A61P
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification
-
公开(公告)号:HRP20040274A2
公开(公告)日:2005-04-30
申请号:HRP20040274
申请日:2004-03-19
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H , STUIVENBERG HERMAN H VAN , DIJKSMAN JESSICA A R , MCCREARY ANDREW C
IPC: C07D277/20 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: The present invention relates to a group of thiazole derivatives which are potent antagonists, agonists or partial agonists of the cannabinoid CB1-receptor. The compounds have the general formula (I) wherein R and R1-R4 have the meanings given in the specification
-
公开(公告)号:AR038966A1
公开(公告)日:2005-02-02
申请号:ARP030100879
申请日:2003-03-13
Applicant: SOLVAY PHARM BV
Inventor: LANGE JOSEPHUS H M , KRUSE CORNELIS G , HERREMANS ARNOLDUS H J , VAN STUIVENBERG HERMAN H , MCCREARY ANDREW C , DIJKSMAN JESSICA A R
IPC: C07D277/20 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/454 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/04 , A61P1/08 , A61P1/12 , A61P1/14 , A61P3/04 , A61P3/10 , A61P7/00 , A61P9/00 , A61P9/10 , A61P11/00 , A61P11/06 , A61P25/00 , A61P25/02 , A61P25/04 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/36 , A61P27/06 , A61P31/04 , A61P31/12 , A61P35/00 , A61P41/00 , A61P43/00 , C07D277/56 , C07D277/68 , C07D417/12
Abstract: Se refiere a un grupo de derivados de tiazol que son potentes antagonistas, agonistas o agonistas parciales del receptor CB1 de cannabinoide, composición farmacéutica, uso para preparar una composición farmacéutica para tratar enfermedades como psicosis, ansiedad, desórdenes cognitivos, obesidad, adicción, desórdenes neurodegenerativos, etc. Reivindicación 1: Derivados de tiazol caracterizados porque son de la fórmula (1) en donde R representa un átomo de hidrógeno o un sustituyente X del grupo alquilo o alcoxi C1-3, ramificado o no ramificado, hidroxi, halógeno, trifluorometilo, trifluorometiltio, trifluorometoxi, nitro, amino, mono- o dialquil (C1-2)amino, mono- o dialquil (C1-2)amido, alcoxi (C1-3)carbonilo ramificado o no ramificado, trifluorometilsulfonilo, sulfamoilo, alquil (C1-3)sulfonilo ramificado o no ramificado, carboxilo, ciano, carbamoilo, dialquil (C1-3)aminosulfonilo ramificado o no ramificado, monoalquil (C1-3)aminosulfonilo ramificado o no ramificado y acetilo, R1 es un átomo de hidrógeno o representa 1-4 sustituyentes X, en donde X tiene el significado anteriormente mencionado, R2 representa un grupo fenilo, tienilo, piridilo, o pirimidinilo, cuyos grupos pueden estar sustituidos con 1-4 sustituyentes X, en donde X tiene el significado anteriormente mencionado o R2 representa naftilo, R3 representa un átomo hidrógeno o un grupo alquilo o cicloalquil-alquilo C1-10, ramificado o no ramificado o un grupo fenilo, bencilo o fenetilo cuyos anillos aromáticos pueden estar sustituidos con 1-5 sustituyentes Z, los cuales pueden ser iguales o diferentes, del grupo alquilo o alcoxi C1-3 ramificado o no ramificado, hidroxi, halógeno, trifluorometilo, trifluorometiltio, trifluorometoxi, nitro, amino, mono o dialquil (C1-2)amino, mono o dialquil (C1-2)amido, alquilsulfonilo (C1-3), ramificado o no ramificado, dimetilsulfamido, alcoxi (C1-3)carbonilo ramificado o no ramificado, carboxilo, trifluorometilsulfonilo, ciano, carbamoilo, sulfamoilo, acetilo, o R3 representa un grupo piridilo o tienilo, R4 representa un grupo alquilo o cicloalquil-alquilo C1-10 ramificado o no ramificado, alcoxi C1-10 ramificado o no ramificado, cicloalquilo C3-8, bicicloalquilo C5-10, tricicloalquilo C6-10, alquenilo C3-10 ramificado o no ramificado, cicloalquenilo C5-8, cuyos grupos pueden contener uno o más heteroátomos del grupo (O, N, S) y cuyos grupos pueden estar sustituidos con un grupo hidroxi, 1-3 grupos metilo, un grupo etilo o 1-3 átomos de flúor, o R4 representa un grupo fenilo, bencilo o fenetilo cuyos anillos aromáticos pueden estar sustituidos con 1-5 sustituyentes Z, en donde Z tiene el significado anteriormente mencionado, o R4 representa un grupo piridilo o tienilo, o R4 representa un grupo NR5R6 en donde R5 y R6 junto con el átomo de nitrógeno al cual están unidos forman un grupo heterocíclico, monocíclico o bicíclico, saturado o insaturado, que tiene 4 a 10 átomos de anillo, cuyo grupo heterocíclico contiene uno o más heteroátomos del grupo (O, N, S) y cuyo grupo heterocíclico puede estar sustituido con un grupo alquilo C1-3 ramificado o no ramificado, hidroxi o trifluorometilo o un átomo de flúor, o R3 y R4 -junto con el átomo de nitrógeno al cual están unidos- forman un grupo heterocíclico monociclico o bicíclico, saturado o insaturado, que tiene 4 a 10 átomos de anillo, cuyo grupo heterocíclico contiene uno o más heteroátomos del grupo (O, N, S) y cuyo grupo heterocíclico puede estar sustituido con un grupo alquilo C1-3 ramificado o no ramificado, hidroxi o trifluorometilo o un átomo de flúor, y prodrogas, estereoisómeros y sales de los mismos.
-
-
-
-
-
-
-
-